Stocks
Santen Pharmaceutical Co., Ltd.SNPHY
OTCHealthcarePharmaceuticals$10.14-0.88%
Focused on ophthalmology, the Japanese drugmaker develops and commercializes prescription pharmaceuticals and medical devices for eye conditions such as glaucoma, dry eye, and retinal disorders. The company generates most of its revenue in Japan while expanding across Asia and Europe, positioning it...
Market Cap: $3.3B52W Range: $8.89 – $12.04
Congressional Interest in Santen Pharmaceutical Co., Ltd. (SNPHY)
1 member of Congress has disclosed 1 trade in Santen Pharmaceutical Co., Ltd. (SNPHY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading SNPHY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-01-27 | Thomas MacArthur | sell | $1K – $15K |